Microbial compound preparation for treating atopic dermatitis

A kind of technology of atopic dermatitis and compound preparation

Pending Publication Date: 2021-09-21
广州市锦盛生物科技有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned types of therapeutic drugs may have side effects. For example, long-term use of glucocorticoids can cause skin atrophy and aggravate infections. The use of immunosuppressants and biological agents may cause other unknown effects in the body
[0005] So far, atopic dermatitis is still incurable and can seriously affect the quality of life, but effective and standardized treatment can relieve symptoms and reduce recurrence; therefore, it has positive significance for the daily treatment management and intervention of atopic dermatitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microbial compound preparation for treating atopic dermatitis
  • Microbial compound preparation for treating atopic dermatitis
  • Microbial compound preparation for treating atopic dermatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A microbial compound preparation for treating atopic dermatitis, consisting of the following parts: 2 parts of Lactobacillus plantarum NumRes8, 1 part of Lactobacillus rhamnosus HN001, 2 parts of fungus polysaccharide, 3 parts of Bifidobacterium longum BB536, 1 part soybean saponin, 1 part Clostridium butyricum JC10390.

[0028] Among them, the amount of inactivated bacteria of Lactobacillus plantarum NumRes8 was 3.5×10 12 individual / g; the amount of inactivated bacteria of Lactobacillus rhamnosus HN001 is 2.5×10 12 Individual / g; the amount of inactivated bacteria of Bifidobacterium longum BB536 is 3.5×10 11 Individual / g; the amount of inactivated bacteria of Clostridium butyricum JC10390 is 2.0×10 9 pcs / g.

Embodiment 2

[0030] A microbial compound preparation for treating atopic dermatitis, consisting of the following parts: 3 parts of Lactobacillus plantarum NumRes8, 2 parts of Lactobacillus rhamnosus HN001, 1 part of fungus polysaccharide, 2 parts of Bifidobacterium longum BB536, 1 part soybean saponin, 1 part Clostridium butyricum JC10390.

[0031] Among them, the amount of inactivated bacteria of Lactobacillus plantarum NumRes8 was 3.1×10 12 individual / g; the amount of inactivated bacteria of Lactobacillus rhamnosus HN001 was 2.8×10 12 Individual / g; the amount of inactivated bacteria of Bifidobacterium longum BB536 is 4.0×10 11 Individual / g; the amount of inactivated bacteria of Clostridium butyricum JC10390 is 1.5×10 9 pcs / g.

Embodiment 3

[0033] A microbial compound preparation for treating atopic dermatitis, consisting of the following parts: 4 parts of Lactobacillus plantarum NumRes8, 1 part of Lactobacillus rhamnosus HN001, 1 part of fungus polysaccharide, 3 parts of Bifidobacterium longum BB536, 0.5 part of soybean saponin, 0.5 part of Clostridium butyricum JC10390.

[0034] Among them, the amount of inactivated bacteria of Lactobacillus plantarum NumRes8 was 3.1×10 12 Individual / g; the amount of inactivated bacteria of Lactobacillus rhamnosus HN001 is 3.1×10 12 Individual / g; the amount of inactivated bacteria of Bifidobacterium longum BB536 is 4.0×10 11Individual / g; the amount of inactivated bacteria of Clostridium butyricum JC10390 is 2.8×10 9 pcs / g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of skin treatment preparations, discloses a microbial compound preparation for treating atopic dermatitis. The microbial compound preparation for treating atopic dermatitis comprises lactobacillus plantarum NumRes8, lactobacillus rhamnosus HN001, agaric polysaccharide, bifidobacterium longum BB536, soybean saponin and clostridium butyricum JC10390. The microbial compound preparation improves the living quality of a patient by adjusting the immunoreaction of the patient, effectively relieves the symptoms of the atopic dermatitis patient, and the related raw materials are easy to obtain, low in cost and free of side effects on a human body, so that a new scheme is provided for treatment and intervention of the atopic dermatitis.

Description

technical field [0001] The invention relates to the technical field of skin treatment preparations, more specifically, to a microbial compound preparation for treating atopic dermatitis. Background technique [0002] Atopic dermatitis is a chronic, relapsing, inflammatory skin disease characterized by recurrent chronic eczema-like rashes, accompanied by marked dryness and itching. Because patients often have other atopic diseases such as allergic rhinitis and asthma, it is considered a systemic disease. [0003] Atopic dermatitis is characterized by obvious "atopic" characteristics seen in patients or their families: ① familial tendency to easily suffer from asthma, allergic rhinitis, and eczema; ② hypersensitivity to foreign proteins; ③ high serum IgE; ④ Increased blood eosinophils. Typical atopic dermatitis has specific clinical manifestations of eczema and the above four characteristics. Also known as atopic dermatitis, atopic eczema, Besnier constitutional prurigo or ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/747A61P17/00A61P37/08A61K31/715A61K35/745A61K35/742A61K31/7048
CPCA61K35/747A61K31/715A61K35/745A61K35/742A61K31/7048A61P17/00A61P37/08A61K2300/00
Inventor 刘卫
Owner 广州市锦盛生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap